Evidence map›Paper›PMID 25712129›Full record

ArticleHuman molecular genetics2015

Loss of the scavenger mRNA decapping enzyme DCPS causes syndromic intellectual disability with neuromuscular defects.

Calista K L Ng, Mohammad Shboul, Valerio Taverniti, Carine Bonnard, Hane Lee, Ascia Eskin, Stanley F Nelson, Mohammed Al-Raqad, Samah Altawalbeh, Bertrand Séraphin and 1 more

Abstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. MFrontiers in genetics · 2022
    Article
  13. Article
  14. Identification of NFrontiers in genetics · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. mRNA decapping: finding the right structures.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Calista K L NgInstitute of Medical Biology, A*STAR, 8A Biomedical Grove, Singapore 138648, Singapore.
Mohammad ShboulInstitute of Medical Biology, A*STAR, 8A Biomedical Grove, Singapore 138648, Singapore.
Valerio TavernitiIGBMC, CNRS UMR 1704/INSERM U964/Université de Strasbourg, Illkirch, France.
Carine BonnardInstitute of Medical Biology, A*STAR, 8A Biomedical Grove, Singapore 138648, Singapore.
Hane LeeDepartment of Pathology and Laboratory Medicine.
Ascia EskinDepartment of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Stanley F NelsonDepartment of Pathology and Laboratory Medicine Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Mohammed Al-RaqadQueen Rania Paediatric Hospital, King Hussein Medical Centre, Royal Medical Services, Amman, Jordan.
Samah AltawalbehQueen Rania Paediatric Hospital, King Hussein Medical Centre, Royal Medical Services, Amman, Jordan.
Bertrand SéraphinIGBMC, CNRS UMR 1704/INSERM U964/Université de Strasbourg, Illkirch, France bertrand.seraphin@igbmc.fr bruno@reversade.com.
Bruno ReversadeInstitute of Medical Biology, A*STAR, 8A Biomedical Grove, Singapore 138648, Singapore Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore bertrand.seraphin@igbmc.fr bruno@reversade.com.

Funding

UCLA Muscular Dystrophy Core CenterP30AR057230 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SPENCER, MELISSA JAN · 2009 to 2018
$6.2M
NIAMS NIH HHS P30-5P30AR057230NIAMS NIH HHS P30 AR057230
6 · The paper itself

Abstract

mRNA decay is an essential and active process that allows cells to continuously adapt gene expression to internal and environmental cues. There are two mRNA degradation pathways: 3' to 5' and 5' to 3'. The DCPS protein is the scavenger mRNA decapping enzyme which functions in the last step of the 3' end mRNA decay pathway. We have identified a DCPS pathogenic mutation in a large family with three affected individuals presenting with a novel recessive syndrome consisting of craniofacial anomalies, intellectual disability and neuromuscular defects. Using patient's primary cells, we show that this homozygous splice mutation results in a DCPS loss-of-function allele. Diagnostic biochemical analyses using various m7G cap derivatives as substrates reveal no DCPS enzymatic activity in patient's cells. Our results implicate DCPS and more generally RNA catabolism, as a critical cellular process for neurological development, normal cognition and organismal homeostasis in humans.

Indexed as

Abnormalities, MultipleCells, CulturedChildChild, PreschoolConsanguinityDNA Mutational AnalysisEndoribonucleasesGenetic Association StudiesHumansIntellectual DisabilityMaleMuscle HypotoniaPedigreeRNA Splice SitesSyndromeDcpS protein, humanEndoribonucleasesRNA Splice Sites

Identifiers

PMID25712129
PMCPMC4424953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.